- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | May 10, 2023
Deals
May 9 Quick Takes: Roche taps Zion for brain-penetrating HER2 program
Plus: Gilead acquires XinThera, Amgen partners with TScan and updates from Ascend, Novavax, Gilead and more
BioCentury | Apr 19, 2023
Data Byte
ADCs overtake mAbs in AACR’s first-in-human abstracts
BioCentury’s analysis of 25 first-in-human studies presented at AACR 2023
BioCentury | Aug 19, 2021
Product Development
Dealmaking and bispecifics cut trail to IPO for Y-Biologics
Korea Spotlight: Y-Biologics’ in-house antibody technology key to series of global partnerships
BioCentury | Mar 30, 2021
Finance
With ADC pipeline now a top priority, Pyxis adds $152M series B
Arix joins syndicate after 12x return on ADC play VelosBio
Items per page:
1 - 4 of 4